Group items tagged

Phosphodiesterase enzyme (PDE) inhibitors is a group of anti-inflammatory drugs that can be useful for the treatment of Crohn's disease (CD) and ulcerative colitis, as well as other inflammatory bowel diseases.

Cellulase is any one of a number of enzymes produced mainly by fungi, bacteria, and some protozoans, which catalyze the decomposition of cellulose and other polysaccharides found in plant, animal, and human cells. Sigma-Aldrich is a major producer of cellulase in Germany. These enzymes are used for commercial food processing in coffee and in textile industry and in laundry detergents.

Alkaline proteases (AKPs) are enzymes that regulate protein and amino acid metabolism in the human body. Over the last two decades, many of these AKPs have been found and characterised. Many additional vital enzymes are produced by the human body and may also be used in the production of therapeutic proteins. However, in most circumstances, the great majority of proteins generated by the body are required for regular physiological activities. This is especially true when it comes to long-term health issues like cancer or major infections.

Apixaban is a new prescription drug that is being introduced into the market to treat patients who have an atrial flutter. It is being designed as an angiotensin Iodine C injection drug. Apixaban works by blocking the effects of the angiotensin II enzyme in the blood. The medication has been shown to improve symptoms of atrial flutter in patients who have been prescribed it. Moreover, smoking is prohibited while using this medicine

The pancreas is an organ in the body that secretes several hormones, including insulin and glucagon, as well as digestive enzymes that help break down food. Insulin helps cells in the body take up glucose (sugar) from the blood to use for energy, which lowers blood glucose levels.

Pompe disease or additionally alluded to as Glycogen stockpiling sickness type II is an autosomal passive metabolic problem that harms nerve cells and muscles all through the body. It is normally caused because of the aggregation of glycogen in the lysosome, inferable from insufficiency of the lysosomal corrosive alpha-glucosidase chemical.

Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body.